Inflammation-Induced Alterations in the Skin Barrier Function: Implications in Atopic Dermatitis
Christian Vestergaard(Aarhus University), Mette Deleuran(Aarhus University Hospital), Bent Deleuran(Aarhus University), Malene Hvid(Aarhus University), Claus Johansen(Aarhus University Hospital), Kaare Kemp(Leo Pharma (Denmark))
Chemical immunology/Fortschritte der Allergielehre/Progress in allergy/Chemical immunology and allergy
January 1, 2012
Cited by 14
Related Papers
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
|New England Journal of Medicine|2016|2.1k
The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
|Allergy|2018|1.5k
European guideline (EuroGuiDerm) on atopic eczema: part I – systemic therapy
|Journal of the European Academy of Dermatology and Venereology|2022|419
Association of Family History of Autoimmune Diseases and Autism Spectrum Disorders
|PEDIATRICS|2009|409
Increasing Comorbidities Suggest that Atopic Dermatitis Is a Systemic Disorder
|Journal of Investigative Dermatology|2016|377